Abstract:PURPOSE:The purpose is to characterize alterations of the annexin I gene, its mRNA, and protein expression in esophageal squamous cell carcinoma.EXPERIMENTAL DESIGN:Fifty-six cases of esophageal squamous cell carcinoma were analyzed using four microsatellite markers flanking the annexin I gene (9q11-q21) to identify loss of heterozygosity. In addition, we performed (a) single-strand conformation polymorphism and DNA sequencing along the entire promoter sequence and coding region to identify mutations, (b) real-time quantitative reverse transcription-PCR of RNA from frozen esophageal squamous cell carcinoma tissue (n = 37) and in situ hybridization (n = 5) on selected cases to assess mRNA expression, and (c) immunohistochemistry (n = 44) to evaluate protein expression. The prevalence of the allelic variants identified in the first 56 patients was refined in 80 additional esophageal squamous cell carcinoma patients and 232 healthy individuals.RESULTS:Forty-six of 56 (82%) esophageal squamous cell carcinoma patients showed loss of an allele at one or more of the four microsatellite markers; however, only one (silent) mutation was seen. Two intragenic variants were identified with high frequency of allelic loss (A58G, 64%; L109L, 69%). Thirty of 37 (81%) esophageal squamous cell carcinoma patients showed reduced annexin I mRNA expression, which was confirmed by in situ hybridization, whereas annexin I protein expression was reduced in 79% of poorly differentiated tumor cell foci but in only 5% of well-differentiated tumor foci, although allelic loss on chromosome 9 was found in both tumor grades.CONCLUSIONS:Allelic loss of annexin I occurs frequently, whereas somatic mutations are rare, suggesting that annexin I is not inactivated in esophageal squamous cell carcinoma via a two-hit mechanism. A decrease in annexin I protein expression was confirmed, consistent with a quantitative decrease in mRNA expression, and appeared to be related to tumor cell differentiation. We conclude that annexin I is not the tumor suppressor gene corresponding to the high levels of loss of heterozygosity observed on chromosome 9 in esophageal squamous cell carcinoma; however, dysregulation of mRNA and protein levels is associated with this tumor type.

Figure S6 from Consistent and Differential Genetic Aberrations between Esophageal Dysplasia and Squamous Cell Carcinoma Detected By Array Comparative Genomic Hybridization

Consistent and Differential Genetic Aberrations Between Esophageal Dysplasia and Squamous Cell Carcinoma Detected by Array Comparative Genomic Hybridization.

Supplementary Table 5 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

ANO1 Protein As a Potential Biomarker for Esophageal Cancer Prognosis and Precancerous Lesion Development Prediction.

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

ANOS1 accelerates the progression of esophageal cancer identified by multi-omic approaches

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Inhibition of Calcium-Activated Chloride Channel ANO1 Suppresses Proliferation and Induces Apoptosis of Epithelium Originated Cancer Cells

Poster 024: Decreased Expression of Annexin A1 Related With Pathologic Differentiation Grade in Oral Squamous Cell Carcinoma

Characterization of Gene Rearrangements Resulted from Genomic Structural Aberrations in Human Esophageal Squamous Cell Carcinoma KYSE150 Cells.

ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis

Identification of chromosome aberrations in esophageal cancer cell line KYSE180 by multicolor fluorescence in situ hybridization.

Supplement File from Consistent and Differential Genetic Aberrations Between Esophageal Dysplasia and Squamous Cell Carcinoma Detected by Array Comparative Genomic Hybridization

Differential Expression of ANXA1 in Benign Human Gastrointestinal Tissues and Cancers

Comprehensive Characterization of Annexin I Alterations in Esophageal Squamous Cell Carcinoma.

Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy

Characterization of Genetic Rearrangements in Esophageal Squamous Carcinoma Cell Lines by a Combination of M-FISH and Array-Cgh: Further Confirmation of Some Split Genomic Regions in Primary Tumors

Supplementary Figure 2 from Amplification and Overexpression of <i>cttn</i> (<i>ems1</i>) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization.

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

Identification And Characterization Of Ano9 In Stage Ii And Iii Colorectal Carcinoma